Although this may be a promising therapeutic target for atherosclerosis, direct use of capsaicin as a TRPV1 agonist in clinical applications is limited by its toxic side effects, such as skin irritation, persistent desensitization and cocarcinogenic effect8, 9. The gene discussed is TRPV1; the disease is atherosclerosis.